Precision Wealth Strategies, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Precision Wealth Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$573.97 - $724.32 $1,721 - $2,172	-3 Reduced 0.75%	395 $291,000
Q2 2022 Jul 14, 2022	SELL	$548.35 - $738.84 $3,290 - $4,433	-6 Reduced 1.49%	398 $240,000
Q1 2022 May 04, 2022	SELL	$595.12 - $698.43 $32,136 - $37,715	-54 Reduced 11.79%	404 $282,000
Q4 2021 Jan 19, 2022	BUY	$543.48 - $670.97 $46,195 - $57,032	85 Added 22.79%	458 $289,000
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $214,113 - $253,998	373 New	373 $226,000

1,484

83.7M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Precision Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Precision Wealth Strategies, LLC with notifications on news.